NAUT peer analysis
Nautilus Biotechnology (NAUT) against its competitors: price, today's move, 1-year return and market value side by side.
NAUT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ARCT Arcturus | $7.99 | 0.25% | 16.49% | $226.98M |
| ASMB Assembly Biosciences | $22.47 | -0.13% | -38.59% | $456.85M |
| ENTA Enanta Pharmaceuticals | $8.21 | -5.47% | -35.41% | $241.16M |
| FHTX Foghorn Therapeutics | $1.79 | -2.19% | -62.37% | $108.53M |
| HUMA Humacyte | $0.49 | -1.56% | -56.63% | $136.15M |
| IMRX Immuneering | $3.49 | 0.87% | -49.71% | $225.38M |
| PYXS Pyxis Oncology | $1.39 | -3.47% | -69.68% | $168.65M |
| SGMT Sagimet Biosciences | $10.08 | 2.34% | 29.71% | $712.56M |
| TNYA Tenaya Therapeutics | $0.31 | -5.48% | -75.40% | $70.66M |
| ZURA Zura Bio | $0.99 | -4.48% | -75.31% | $94.88M |
| NAUT Nautilus Biotechnology | $2.40 | 1.69% | 26.05% | $305.06M |
- NAUT's peers: ARCT (Arcturus), ASMB (Assembly Biosciences), ENTA (Enanta Pharmaceuticals), FHTX (Foghorn Therapeutics), HUMA (Humacyte), IMRX (Immuneering), PYXS (Pyxis Oncology), SGMT (Sagimet Biosciences).
Updated 2026-11-19 00:45 UTC